Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Mustafa, S Shahzad; Ostrov, David; Yerly, Daniel (2018). Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management. Current allergy and asthma reports, 18(4), p. 26. Springer 10.1007/s11882-018-0778-6

Text s11882-018-0778-6.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (705kB)

PURPOSE OF STUDY

Immune-mediated adverse drug reactions occur commonly in clinical practice and include mild, self-limited cutaneous eruptions, IgE-mediated hypersensitivity, and severe cutaneous adverse drug reactions (SCAR). SCARs represent an uncommon but potentially life-threatening form of delayed T cell-mediated reaction. The spectrum of illness ranges from acute generalized exanthematous pustulosis (AGEP) to drug reaction with eosinophilia with systemic symptoms (DRESS), to the most severe form of illness, Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).

RECENT FINDINGS

There is emerging literature on the efficacy of cyclosporine in decreasing mortality in SJS/TEN. The purpose of our review is to discuss the typical presentations of these conditions, with a special focus on identifying the culprit medication. We review risk factors for developing SCAR, including HLA alleles strongly associated with drug hypersensitivity. We conclude by discussing current strategies for the management of these conditions.

Interest & Impact

Downloads

1 since deposited on 04 Feb 2019
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item